Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Divestments (2019 - 2021)

Silo Pharma (SILO) has disclosed Divestments for 2 consecutive years, with $284456.0 as the latest value for Q4 2021.

  • Quarterly Divestments changed N/A to $284456.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $284456.0 through Dec 2022, changed N/A year-over-year, with the annual reading at $66707.0 for FY2022, 99.05% down from the prior year.
  • Divestments hit $284456.0 in Q4 2021 for Silo Pharma, up from $132951.0 in the prior quarter.
  • In the past five years, Divestments ranged from a high of $284456.0 in Q4 2021 to a low of $132951.0 in Q3 2019.